GlassScriptPhysician profile
Jay Erwin Tiongson
NPI 1609082312
$43,177.20
in general payments reported to CMS, 2019-2025
28 companies · $4,421 in 2025
The $4,421 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,919 · 2020: $315 · 2021: $5,561 · 2022: $6,868 · 2023: $14K · 2024: $7,596 · 2025: $4,421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,484 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,354 · Travel and Lodging: $6,464 · Consulting Fee: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,484.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,354.00 |
| Travel and Lodging | $6,463.70 |
| Consulting Fee | $1,212.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19,270.34 | 2019-2025 | Lifevest |
| Abbott Laboratories | $5,383.07 | 2019-2025 | Aveir, Perclose Prostyle, Ensite |
| E.R. Squibb & Sons, L.L.C. | $3,942.53 | 2019-2025 | Eliquis |
| Medtronic, INC. | $3,210.14 | 2021-2025 | Affera Mapping System, Cardioblate, Linq II |
| Biosense Webster, INC. | $2,540.58 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro |
| Boston Scientific Corporation | $2,045.69 | 2019-2025 | Watchman Access System, General - Therapies, Lux-Dx Insertable Cardiac Monitor |
| Acutus Medical, INC. | $1,413.57 | 2021-2023 | |
| Cvrx, INC. | $1,219.77 | 2024-2025 | Barostim Neo System |
| Biotronik INC. | $1,210.73 | 2019-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Medtronic Vascular, INC. | $689.94 | 2019 | |
| Pfizer INC. | $579.80 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $430.28 | 2019-2024 | Xarelto |
| Infobionic, INC | $283.88 | 2025 | Mome Device |
| Sanofi-Aventis U.S. LLC | $219.84 | 2019-2024 | |
| Philips North America LLC | $169.20 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $152.57 | 2022-2025 | Assure Wcd |
| Atricure, INC. | $119.49 | 2022 | |
| Edwards Lifesciences Corporation | $60.09 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Altathera Pharmaceuticals LLC | $48.00 | 2024-2025 | Sotalol Hydrochloride |
| Impulse Dynamics (USA) INC. | $29.55 | 2022 | |
| Chiesi USA, INC. | $26.92 | 2025 | Kengreal |
| Amgen INC. | $24.32 | 2019 | |
| Stereotaxis INC | $21.50 | 2022 | |
| Portola Pharmaceuticals, LLC | $21.41 | 2019 | |
| Cardiofocus, INC. | $19.75 | 2022 | |
| Lundbeck LLC | $17.52 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $14.80 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Tiongson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.